Bordetella pertussis polymorphism and pertussis vaccines.
作者信息
Guiso Nicole
出版信息
Clin Vaccine Immunol. 2008 Feb;15(2):394; author reply 394-5. doi: 10.1128/CVI.00391-07.
Abstract
摘要
相似文献
1
Bordetella pertussis polymorphism and pertussis vaccines.
Clin Vaccine Immunol. 2008 Feb;15(2):394; author reply 394-5. doi: 10.1128/CVI.00391-07.
2
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23.
3
Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens.
FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):121-8. doi: 10.1016/S0928-8244(03)00068-3.
4
Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence.
Infect Genet Evol. 2016 Jun;40:136-143. doi: 10.1016/j.meegid.2016.02.032. Epub 2016 Feb 27.
5
Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.
Infect Immun. 1998 Feb;66(2):670-5. doi: 10.1128/IAI.66.2.670-675.1998.
6
Do Pertussis Vaccines Protect Against Bordetella parapertussis?
Clin Infect Dis. 2017 Jun 15;64(12):1795-1797. doi: 10.1093/cid/cix221.
7
Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
Vaccine. 2005 Jul 29;23(34):4353-8. doi: 10.1016/j.vaccine.2005.03.033.
8
Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
Microbiol Immunol. 2016 Sep;60(9):599-608. doi: 10.1111/1348-0421.12409.
9
Bordetella pertussis fimbriae (Fim): relevance for vaccines.
Expert Rev Vaccines. 2014 Oct;13(10):1205-14. doi: 10.1586/14760584.2014.930667. Epub 2014 Aug 8.
10
The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.
Hum Vaccin Immunother. 2016 May 3;12(5):1274-6. doi: 10.1080/21645515.2015.1137402. Epub 2016 Feb 18.
本文引用的文献
1
Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Clin Vaccine Immunol. 2007 Nov;14(11):1490-8. doi: 10.1128/CVI.00177-07. Epub 2007 Aug 15.
2
Pertussis in Argentina and France.
Vaccine. 2007 May 30;25(22):4335-9. doi: 10.1016/j.vaccine.2006.08.024. Epub 2006 Aug 31.
3
Detection and differentiation of Bordetella spp. by real-time PCR.
J Clin Microbiol. 2007 Feb;45(2):347-50. doi: 10.1128/JCM.01303-06. Epub 2006 Dec 6.
4
Multitarget PCR for diagnosis of pertussis and its clinical implications.
J Clin Microbiol. 2007 Feb;45(2):506-11. doi: 10.1128/JCM.02042-06. Epub 2006 Dec 6.
5
Nucleic Acid amplification tests for diagnosis of Bordetella infections.
J Clin Microbiol. 2005 Oct;43(10):4925-9. doi: 10.1128/JCM.43.10.4925-4929.2005.
6
Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies.
Microbes Infect. 2005 Jun;7(7-8):976-82. doi: 10.1016/j.micinf.2005.04.005.
7
Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.
Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):174-81. doi: 10.1007/s100960050455.
8
Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines.
Vaccine. 1999 May 14;17(19):2366-76. doi: 10.1016/s0264-410x(99)00037-7.
Zotero 插件